Home › Entities › clinical_trial › A Study for Patients With Relapsing Remitting Multiple Sclerosis

A Study for Patients With Relapsing Remitting Multiple Sclerosis

clinical trial
MedicalStudy clinical_trial Q61980678
Press Enter · cited answer in seconds

A Study for Patients With Relapsing Remitting Multiple Sclerosis

Summary

A Study for Patients With Relapsing Remitting Multiple Sclerosis is a clinical trial[1].

Key Facts

  • A Study for Patients With Relapsing Remitting Multiple Sclerosis is in the country of Bulgaria[2].
  • A Study for Patients With Relapsing Remitting Multiple Sclerosis is in the country of Poland[3].
  • A Study for Patients With Relapsing Remitting Multiple Sclerosis is in the country of Serbia[4].
  • A Study for Patients With Relapsing Remitting Multiple Sclerosis is in the country of Slovakia[5].
  • A Study for Patients With Relapsing Remitting Multiple Sclerosis is in the country of Ukraine[6].
  • A Study for Patients With Relapsing Remitting Multiple Sclerosis's instance of is recorded as clinical trial[7].
  • A Study for Patients With Relapsing Remitting Multiple Sclerosis's start time is recorded as +2006-11-30T00:00:00Z[8].
  • A Study for Patients With Relapsing Remitting Multiple Sclerosis's end time is recorded as +2009-09-30T00:00:00Z[9].
  • A Study for Patients With Relapsing Remitting Multiple Sclerosis's sponsor is recorded as Eli Lilly and Company[10].
  • A Study for Patients With Relapsing Remitting Multiple Sclerosis's main subject is recorded as sclerosis[11].
  • A Study for Patients With Relapsing Remitting Multiple Sclerosis's main subject is recorded as multiple sclerosis[12].
  • A Study for Patients With Relapsing Remitting Multiple Sclerosis's number of participants is recorded as {'unit': '1', 'amount': '+218'}[13].
  • A Study for Patients With Relapsing Remitting Multiple Sclerosis's title is recorded as A Double Blind, Placebo Controlled Multi-Center Study to Evaluate the Efficacy and Safety of MBP8298 in Relapsing Remitting Multiple Sclerosis[14].
  • A Study for Patients With Relapsing Remitting Multiple Sclerosis's short name is recorded as MINDSET01[15].
  • A Study for Patients With Relapsing Remitting Multiple Sclerosis's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+18'}[16].
  • A Study for Patients With Relapsing Remitting Multiple Sclerosis's ClinicalTrials.gov ID is recorded as NCT00869986[17].
  • A Study for Patients With Relapsing Remitting Multiple Sclerosis's maximum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+50'}[18].
  • A Study for Patients With Relapsing Remitting Multiple Sclerosis's clinical trial phase is recorded as phase II clinical trial[19].
  • A Study for Patients With Relapsing Remitting Multiple Sclerosis's clinical trial phase is recorded as phase III clinical trial[20].
  • A Study for Patients With Relapsing Remitting Multiple Sclerosis's research subject recruitment status is recorded as completed[21].
  • A Study for Patients With Relapsing Remitting Multiple Sclerosis's study type is recorded as interventional study[22].

References

Programmatic citations — every numbered marker resolves to a verifiable graph row below.

Direct Wikidata claims

  1. [2] ↑ . wikidata.org.
  2. [3] ↑ . wikidata.org.
  3. [4] ↑ . wikidata.org.
  4. [5] ↑ . wikidata.org.
  5. [6] ↑ . wikidata.org.
  6. [7] ↑ . wikidata.org.
  7. [8] ↑ . wikidata.org.
  8. [9] ↑ . wikidata.org.
  9. [10] ↑ . wikidata.org.
  10. [11] ↑ . wikidata.org.
  11. [12] ↑ . wikidata.org.
  12. [13] ↑ . wikidata.org.
  13. [14] ↑ . wikidata.org.
  14. [15] ↑ . wikidata.org.
  15. [16] ↑ . wikidata.org.
  16. [17] ↑ . wikidata.org.
  17. [18] ↑ . wikidata.org.
  18. [19] ↑ . wikidata.org.
  19. [20] ↑ . wikidata.org.
  20. [21] ↑ . wikidata.org.
  21. [22] ↑ . wikidata.org.

Class ancestry

  1. [1] ↑ . Wikidata. wikidata.org.

📑 Cite this page

Use these citations when quoting this entity in research, articles, AI prompts, or wherever provenance matters. We aggregate Wikidata + Wikipedia + authoritative open-data sources; the stitched, scored, cross-referenced view is what 4ort.xyz contributes.

APA 4ort.xyz Knowledge Graph. (2026). A Study for Patients With Relapsing Remitting Multiple Sclerosis. Retrieved May 3, 2026, from https://4ort.xyz/entity/a-study-for-patients-with-relapsing-remitting-multiple-sclerosis
MLA “A Study for Patients With Relapsing Remitting Multiple Sclerosis.” 4ort.xyz Knowledge Graph, 4ort.xyz, 3 May. 2026, https://4ort.xyz/entity/a-study-for-patients-with-relapsing-remitting-multiple-sclerosis.
BibTeX @misc{4ortxyz_a-study-for-patients-with-relapsing-remitting-multiple-sclerosis_2026, author = {{4ort.xyz Knowledge Graph}}, title = {{A Study for Patients With Relapsing Remitting Multiple Sclerosis}}, year = {2026}, url = {https://4ort.xyz/entity/a-study-for-patients-with-relapsing-remitting-multiple-sclerosis}, note = {Accessed: 2026-05-03}}
LLM prompt According to 4ort.xyz Knowledge Graph (aggregator of Wikidata, Wikipedia, and authoritative open-data sources): A Study for Patients With Relapsing Remitting Multiple Sclerosis — https://4ort.xyz/entity/a-study-for-patients-with-relapsing-remitting-multiple-sclerosis (retrieved 2026-05-03)

Canonical URL: https://4ort.xyz/entity/a-study-for-patients-with-relapsing-remitting-multiple-sclerosis · Last refreshed: